跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Lipitor - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Lipitor
Approved
STANDARD
Lipitor
Pfizer Pharmaceuticals LLC
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
ab3a48fb6b2c5d03
Company
Pfizer Pharmaceuticals LLC
Type
Standard
Approval Details
Approval Id
ab3a48fb6b2c5d03
Drug Approval Philippines Name
Lipitor
Product Name
Lipitor
Registration Number
DRP-3363
Brand Name
Lipitor
Generic Name
Atorvastatin (as calcium)
Dosage Form
Tablet
Dosage Strength
40mg
Manufacturer
Pfizer Pharmaceuticals LLC
Trader
Under Authority by: Pfizer, Inc.
Importer
Pfizer, Inc.
Company Detail Path
/organization/pfizer-pharmaceuticals-inc
Importer Detail Path
/organization/pfizer-inc-pleasant-prairie-wisconsin-united-states
Issuance Date
26 March 2022
Expiry Date
29 June 2027
Pharmacologic Category
HMG CoA Reductase Inhibitor
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
ab3a48fb6b2c5d03
Type
Standard
Back to Philippines FDA Approvals